[
    [
        {
            "time": "",
            "original_text": "长春高新：控股子公司金妥利珠单抗注射液获药物临床试验批准",
            "features": {
                "keywords": [
                    "长春高新",
                    "金妥利珠单抗注射液",
                    "药物临床试验",
                    "批准"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新：控股子公司金妥利珠单抗注射液获药物临床试验批准",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "长春高新(000661.SZ)：金妥利珠单抗注射液获批开展血液系统恶性肿瘤、晚期恶性实体瘤和淋巴瘤的临床试验",
            "features": {
                "keywords": [
                    "长春高新",
                    "金妥利珠单抗注射液",
                    "临床试验",
                    "血液系统恶性肿瘤",
                    "晚期恶性实体瘤",
                    "淋巴瘤"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新(000661.SZ)：金妥利珠单抗注射液获批开展血液系统恶性肿瘤、晚期恶性实体瘤和淋巴瘤的临床试验",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09",
            "original_text": "医药行业2020年9月投资月报：建议关注IVD化学发光赛道 业绩高增长可期",
            "features": {
                "keywords": [
                    "医药行业",
                    "IVD化学发光",
                    "投资月报",
                    "业绩高增长"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年9月投资月报：建议关注IVD化学发光赛道 业绩高增长可期",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "生长激素龙头长春高新上半年净利增长超8成，不断丰富产品线布局下半年业绩增长有望加速丨领航100",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "净利增长",
                    "产品线布局",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生长激素龙头长春高新上半年净利增长超8成，不断丰富产品线布局下半年业绩增长有望加速丨领航100",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]